Cited by 170Mobile Health and mHealth ApplicationsDiabetes Management and EducationDiabetes Management and Research

Rapid evidence review of mobile applications for self-management of diabetes

Open access
Veazie, Stephanie, Winchell, Kara, Gilbert, Jennifer, Paynter, Robin, Ivlev, Ilya, Eden, Karen B., Nussbaum, Kerri, Weiskopf, Nicole +2 more·2018·Journal of General Internal Medicine

Abstract

Background Patients with diabetes lack information on which commercially available applications (apps) improve diabetes-related outcomes. We conducted a rapid evidence review to examine features, clinical efficacy, and usability of apps for self-management of type 1 and type 2 diabetes in adults.Methods Ovid/Medline and the Cochrane Database of Systematic Reviews were searched for systematic reviews and technology assessments. Reference lists of relevant systematic reviews were examined for primary studies. Additional searches for primary studies were conducted online, through Ovid/Medline, Embase, CINAHL, and ClinicalTrials.gov . Studies were evaluated for eligibility based on predetermined criteria, data were extracted, study quality was assessed using a risk of bias tool, information on app features was collected, and app usability was assessed. Results are summarized qualitatively.Results Fifteen articles evaluating 11 apps were identified: six apps for type 1 and five apps for type 2 diabetes. Common features of apps included setting reminders and tracking blood glucose and hemoglobin A1c (HbA1c), medication use, physical activity, and weight. Compared with controls, use of eight apps, when paired with support from a healthcare provider or study staff, improved at least one outcome, most often HbA1c. Patients did not experience improvements in quality of life, blood pressure, or weight, regardless of app used or type of diabetes. Study quality was variable. Of the eight apps available for usability testing, two were scored "acceptable," three were "marginal," and three were "not acceptable."Discussion Limited evidence suggests that use of some commercially available apps, when combined with additional support from a healthcare provider or study staff, may improve some short-term diabetes-related outcomes. The impact of these apps on longer-term outcomes is unclear. More rigorous and longer-term studies of apps are needed.Registration This review was funded by the Agency for Healthcare Research and Quality (AHRQ). The protocol is available at: http://www.effectivehealthcare.ahrq.gov/topics/diabetes-mobile-devices/research-protocol .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11606-018-4410-1

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prescription of mHealth programmes from healthcare practice is scarce due to the lack of randomized controlled trials that determine their effectiveness on clinical outcomes.

    “However, the prescription of mHealth programmes from healthcare practice is scarce due to the lack of randomized controlled trials that determine their effectiveness on clinical outcomes [16,17].”

    From Impact of a primary care-based mobile health intervention to ‘sit less and move more’ on HbA1c, blood pressure, and other clinical outcomes in office employees with type 2 diabetes: A randomized controlled trial (2025) · cites this paper as [16]

    The Summary of Evidence and Conclusion and Next Steps (pages unavailable) describe limited evidence for commercially available diabetes apps and call for more rigorous, longer-term studies of clinical outcomes. The paper does not say that prescribing mHealth programmes in healthcare practice is scarce or that a shortage of randomized trials causes scarce prescribing; its Apps for Type 2 Diabetes section reports six randomized controlled trials. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Veazie, S., Winchell, K., Gilbert, J., Paynter, R., Ivlev, I., Eden, K. B., Nussbaum, K., Weiskopf, N., Guise, J.-M., & Helfand, M.
Affiliations
  • Portland VA Research Foundation (US)
  • Oregon Health & Science University (US)
Corresponding author
Veazie, Stephanie
Venue
Journal of General Internal Medicine
Published
2018-05-08
Volume
33
Issue
7
Pages
1167-1176
ISSN
  • 0884-8734 (ISSN-L)
  • 1525-1497
OpenAlex
W2800324513
Cited by
170
References
31
Citations by year
2026: 10 · 2025: 20 · 2024: 11 · 2023: 24 · 2022: 25 · 2021: 31 · 2020: 27 · 2019: 18 · 2018: 4
FWCI
30.55
Type
journal article
Language
en
Open access
Locations
  • Journal of General Internal Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health and Human Services
  • AcademyHealth
  • National Institutes of Health
  • Agency for Healthcare Research and Quality (HHSA 290 2017 00003C)
  • U.S. National Library of Medicine (T15LM007088)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
mobile health apps, diabetes self-management, type 1 diabetes, type 2 diabetes, glycemic control, HbA1c, blood glucose monitoring, medication adherence, physical activity monitoring, app usability, healthcare provider support, quality of life
MeSH terms
Self-Management, Diabetes Mellitus, Humans, Self Care, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Cell Phone, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review